Maurice O Connell

🎥 Watch my ISCB46 presentation 🩺📊 Causal ML methods for deprescribing meds in polypharmacy patients using EHRs. 👉 Full recording: youtu.be/qLrSZJ4ZAx8?t=… @OfficialUoM #CausalMachineLearning

Look at all those attendees! 👀 We are currently hosting over 100 attendees here at Institute, bringing together a massive range of expertise to kick off the CIF* programme. #NewtonCIF2026 #isaacnewtoninstitute

Developing an AI-Assisted Tool That Identifies Patients With Multimorbidity and Complex Polypharmacy to Improve the Process of Medication Reviews: Qualitative Interview and Focus Group Study dlvr.it/TQDvty

Excited to present my work at #ISCB46 in Basel, Switzerland, hosted by @UniBasel and @ETH ! Grateful to share ideas on causal inference and polypharmacy research @OfficialUoM with the international clinical statistics community @ISCB_info - and enjoy the city with my family

Grateful to present recent research @SFU International Conference in Statistics & Data Science 2025 Simon Fraser University in Vancouver on #TargetTrialEmulation using electronic health records to estimate average treatment effects & #CausalML conditional average treatment effect

“An automation framework for clinical codelist development validated with UK data from patients with multiple long-term conditions.”#polypharmacy #multimorbidity #ElectronicHealthRecords @dynairx doi.org/10.1186/s12874…

@turinginst @AIM_RSF @MatthewSperrin @dynairx @OfficialUoM Slides are available here zenodo.org/records/150505… from this talk youtu.be/z0CtfYnu3b8?si…

You can view the recording of my online talk @turinginst @AIM_RSF here on YouTube on #causalinference #TargetTrial emulation #CausalMachineLearning #polypharmacy & #deprescribing on research with @MatthewSperrin @dynairx @OfficialUoM youtu.be/z0CtfYnu3b8?si…

Free registration link & info below on online talk @turinginst @AIM_RSF on #causalinference arsenal @OfficialUoM with @dynairx team & @MatthewSperrin Stopping or continuing\initiating medications in population with #polypharmacy #multimorbidity #EHR turing.ac.uk/events/overvie…

@dynairx research posters and @MatthewSperrin presentation at the "Pioneering #AI in Multiple Long Term Conditions: Bridging Research and Practice Conference" conference in Manchester funded by @NIHRresearch

"A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study" #polypharmacy #multimorbidity @dynairx doi.org/10.1371/journa…

There are a lot of components of @dynairx, but collaborating with our Public Advisor team is an important part of the study. Congrats to WP3 on delivering understandable presentations on their technical roles. There will be opportunities to join our PPIE group soon. Join us! 🤝

**New R package** graphPAF: Need to estimate or display population attributable fractions? Our new R package, “graphPAF”, could help: built with Dr John Ferguson. doi.org/10.1007/s10654…

Thanks to everyone who came to our Communicating AI in Health Research workshop @LivUniCHIL today! It was packed with conversation and sharing of good practice, as well as a truly fantastic group of researchers and public advisors. #ComeBackSoon

A qualitative exploration of barriers to efficient and effective Structured Medication Reviews in Primary Care: Findings from the DynAIRx study medrxiv.org/cgi/content/sh… #medRxiv

Throwback to Monday's DynAIRx PPIE workshop @LivUniCHIL. Such a positive start to the week. When you are a cross institution team @LivUni @UofGlasgow @UniversityLeeds @OfficialUoM, opportunities to meet F2F are limited, making it extra valuable when you do. #collaboration

@profbuchan welcomed the @dynairx team to CHIL for a PPIE workshop. DynAIRx exemplifies the multi-disciplinary collaborative approach CHIL is taking to solving health challenges.

The research team and public advisors co-creating descriptions of the different strands of DynAIRx's work

Great to present @turinginst in London at the ECR event by @AIM_RSF with colleagues @AsraAslam14 @mile265 and @cattiehant on @dynairx project which addresses potentially problematic polypharmacy in key multimorbidity groups with presentations on AI, NLP and causal inference.